Ascorbic acid for the prevention of contrast-induced nephropathy after coronary angiography in patients with chronic renal impairment: A randomized controlled trial

Therapeutic Apheresis and Dialysis

Volumn 17, Issue 4, 2013, Pages 384-390

  Dvoršak, Benjamin ^a   Kanič, Vojko ^a   Ekart, Robert ^a   Bevc, Sebastjan ^a   Hojs, Radovan ^a  

^a UNIVERSITY MEDICAL CENTRE MARIBOR   (Slovenia)

Author keywords

Ascorbic acid; Contrast media; Contrast induced nephropathy; Coronary angiography; Renal insufficiency

Indexed keywords

ASCORBIC ACID; CREATININE; CYSTATIN C; PLACEBO;

ADULT; AGED; ANGIOCARDIOGRAPHY; ANGIOPLASTY; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL EFFECTIVENESS; CONTRAST INDUCED NEPHROPATHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; FOLLOW UP; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ASCORBIC ACID; CONTRAST MEDIA; CONTRAST-INDUCED NEPHROPATHY; CORONARY ANGIOGRAPHY; RENAL INSUFFICIENCY;

AGED; AGED, 80 AND OVER; ANTIOXIDANTS; ASCORBIC ACID; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; CREATININE; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; TREATMENT OUTCOME;

EID: 84881522958     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/1744-9987.12083     Document Type: Article

References (41)

1. Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis 2002;39:930-936.
2. McCollough PA, Sandberg KR. Epidemiology of contrast-induced nephropathy. Rev Cardiovasc Med 2003;4:53-59.
3. McCollough PA, Wolyn R, Rocher LL etal. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 1997;103:368-375.
4. Iakovu I, Dangas G, Mehran R etal. Impact of gender on the incidence and outcome of contrast-induced nephropathy after percutaneous coronary intervention. J Invasive Cardiol 2003;15:18-22.
5. Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality. A cohort analysis. JAMA 1996;175:1489-1494.
6. Rihal CS, Textor SC, Grill DE etal. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002;105:2259-2264.
7. Lindsay J, Apple S, Pinnow EE. Percutaneous coronary intervention-associated nephropathy foreshadows increased risk of late adverse events in patients with normal baseline serum creatinine. Catheter Cardiovasc Interv 2003;59:338-343.
8. McCullough PA, Adam A, Becker CR etal. Epidemiology and prognostic implications of contrast-induced nephropathy. Am J Cardiol 2006;98(Suppl):5K-13K.
9. Kitajima K, Maeda T, Watanabe S, Sugimura K. Recent issues in contrast-induced nephropathy. Int J Urol 2011;18:686-690.
10. Nikolsky E, Mehran R, Turcot DB etal. Impact of chronic kidney disease on prognosis of patients with diabetes mellitus treated with percutaneous coronary intervention. Am J Cardiol 2004;94:300-305.
11. McCollough PA, Adam A, Becker CR etal. Risk prediction of contrast-induced nephropathy. Am J Cardiol 2006;98:27K-36K.
12. McCollough PA. Contrast-induced acute kidney injury. J Am Coll Cardiol 2008;51:1419-1428.
13. Marenzi G, Lauri G, Assanelli E etal. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 2004;44:1780-1785.
14. Wong PCY, Li Z, Guo J, Zhang A. Pathophysiology of contrast-induced nephropathy. Int J Cardiol 2012;158:186-192.
15. Evans RG, Gardiner BS, Smith DW etal. Intrarenal oxygenation: unique challenges and the biophysical basis of homeostasis. Am J Physiol Renal Physiol 2008;295:F1259-1270.
16. Brezis M, Rosen S. Hypoxia of the renal medulla-its implications for disease. N Engl J Med 1995;332:647-655.
17. Brenner BM, Troy JL, Ballermann BJ. Endothelium-dependent vascular responses. Mediators and mechanisms. J Clin Invest 1989;84:1373-1378.
18. Myers SI, Wang L, Liu F etal. Iodinated contrast induced renal vasoconstriction is due in part to the downregulation of renal cortical and medullary nitric oxide synthesis. J Vasc Surg 2006;44:383-391.
19. Morris TW, Katzberg RW, Fisher HW. A comparison of the hemodynamic responses to metrizamide and meglumine/sodium diatrizoat in canine renal angiography. Invest Radiol 1978;13:74-78.
20. Tumlin J, Stacul F, Adam A etal. Pathophysiology of contrast-induced nephropathy. Am J Cardiol 2006;98(Suppl):14K-20K.
21. Ribeiro L, de Assuncao e Silva S, Kurihara RS, Schor N, Mieko E, Higa S. Evaluation of the nitric oxide production in rat renal artery smooth muscle cells culture exposed to radiocontrast agents. Kidney Int 2004;65:589-596.
22. Heyman SN, Brezis M, Reubinoff CA etal. Acute renal failure with selective medullary injury in the rat. J Clin Invest 1988;82:401-412.
23. Moreau JF, Droz D, Noel LH, Leibowitch J, Jungers P, Michel JR. Tubular nephrotoxicity of water-soluble iodinated contrast media. Invest Radiol 1980;15:S54-S60.
24. Davidson C, Stacul F, McCullough PA etal. Contrast medium use. Am J Cardiol 2006;98(Suppl):42K-58K.
25. Stacul F, Adam A, Becker CR etal. Strategies to reduce the risk of contrast-induced nephropathy. Am J Cardiol 2006;98(Suppl):59K-77K.
26. Stacul F, van der Molen AJ, Reimer P etal. Contrast induced nephropathy: updated ESUR contrast media safety committee guidelines. Eur Radiol 2011;21:2527-2541.
27. Spargias K, Alexopoulos E, Kyrzopoulos S etal. Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. Circulation 2004;110:2837-2842.
28. Boscheri A, Weinbrenner C, Botzek B etal. Failure of ascorbic acid to prevent contrast-media induced nephropathy in patients with renal dysfunction. Clin Nephrol 2007;68:279-286.
29. Aguiar-Souto P, Ferrante G, Del Furia F etal. Frequency and predictors of contrast-induced nephropathy after angioplasty for chronic total occlusions. Int J Cardiol 2010;139:68-74.
30. Gruberg L, Mintz GS, Mehran R etal. The prognostic implications of further renal function deterioration within 48h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol 2000;36:1542-1548.
31. Solomon R, DuMouchel W. Contrast media and nephropathy. Invest Radiol 2006;41:651-660.
32. Aspelin P, Aubry P, Fransson SG etal. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 2003;348:491-499.
33. Zaytseva NV, Shamkhalova MS, Shestakova MV etal. Contrast-induced nephropathy in patients with type 2 diabetes during coronary angiography: risk factors and prognostic value. Diabetes Res Clin Pract 2009;86S:S63-S69.
34. Briguori C, Airoldi F, D'Andrea D etal. Renal insufficiency following contrast media administration trial (REMEDIAL): a randomized comparison of 3 preventive strategies. Circulation 2007;115:1211-1217.
35. Huber W, Jeschke B, Kreymann B etal. Haemodialysis for the prevention of contrast-induced nephropathy: outcome of 31 patients with severely impaired renal function, comparison with patients at similar risk and review. Invest Radiol 2002;37:471-481.
36. Frei B, England L, Ames BN. Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci U S A 1989;86:63-77.
37. Pazirandeh S, Lo CW, Burns DL. Overview of water-soluble vitamins. In: Basow DS, ed. UpToDate. Waltham, MA: UpToDate, 2012. Available from URL: http://www.uptodateonline.com.
38. Li Y, Schellhorn HE. New developments and therapeutic perspectives for vitamin C. J Nutr 2007;137:2171-2184.
39. Gokce N, Keaney JF, Frey B etal. Long-term ascorbic acid administration reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 1999;99:3234-3240.
40. Delles C, Schneider MP, Oehmer S etal. Increased response of renal perfusion to the antioxidant vitamin C in type 2 diabetes. Nephrol Dial Transplant 2004;19:2513-2518.
41. Padayatty SJ, Levine M. New insights into the physiology and pharmacology of vitamin C. CMAJ 2001;164:353-355.